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Background: The enzymatic activity of the four proteases found in the house dust mite Dermatophagoides
pteronyssinus is involved in the pathogenesis of allergy. Our aim was to elucidate the activation cascade of
their corresponding precursor forms and particularly to highlight the interconnection between proteases during
this cascade.
Methods: The cleavage of the four peptides corresponding to the mite zymogen activation sites was studied on
the basis of the Förster Resonance Energy Transfermethod. The proDer p 6 zymogenwas then produced in Pichia
pastoris to elucidate its activation mechanism bymite proteases, especially Der p 1. The role of the propeptide in
the inhibition of the enzymatic activity of Der p 6 was also examined. Finally, the Der p 1 and Der p 6 proteases
were localised via immunolocalisation in D. pteronyssinus.
Results: All peptides were speciﬁcally cleaved by Der p 1, such as proDer p 6. The propeptide of proDer p 6
inhibited the proteolytic activity of Der p 6, but once cleaved, it was degraded by the protease. The Der p 1 and
Der p 6 proteases were both localised to the midgut of the mite.
Conclusions:Der p 1 in either its recombinant formor in the natural context of house dustmite extracts speciﬁcally
cleaves all zymogens, thus establishing its role as a major activator of both mite cysteine and serine proteases.
General signiﬁcance: This ﬁnding suggests that Der p 1 may be valuable target against mites.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
The house dust mite Dermatophagoides pteronyssinus is the primary
source of allergens that are involved in the development of allergy leading
to asthma, rhinitis or atopic dermatitis. Today, more than 20 groups of
house dust mite (HDM) allergens have been identiﬁed, among which
groups 1, 3, 6 and9 correspond to secretedproteases [1,2]. Theproteolytic
activity of these allergens has been shown to enhance the development
and the chronicity of allergy either by cleaving receptors, leading to the
activation of innate or adaptive immunity, or by increasing the perme-
ability of the airway epithelium, promoting allergen penetration [3–6].
These proteases are expected to be involved in biological processes
in the mite. Indeed, Der p 1 [7,8] and Der f 3, the homolog of Der p 3
in Dermatophagoides farinae [9], are localised to the gut of mites and
to HDM faecal pellets, suggesting that they play a role in digestion.
Similar to other digestive proteases, Der p 1, Der p 3, Der p 6 and Der
p 9 are synthesised as inactive precursors to control enzyme activation.
These zymogens are termed proDer p 1, proDer p 3, proDer p 6 and
proDer p 9. Investigating the activation mechanisms of these zymogens
is crucial for understanding the pattern of allergenic proteases in the
environment.
The activation of Der p 1, a cysteine protease from the papain family,
has beenwidely characterised. The Der p 1 propeptide (80 amino acids)
plays an essential role in zymogen folding (as an intramolecular chaper-
one) and in the inhibition of its own enzymatic activity. ProDer p 1 was
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shown to activate itself through a multistep mechanism at an acidic pH
[10].
Dumez et al. [11] have shown that the short propeptide (11 amino
acids) of Der p 3, a serine trypsin-like protease, is mainly involved in
inhibition of the protease. However, once proDer p 3 is activated by
Der p 1 through intermolecular cleavage of the propeptide, the latter
loses its inhibitory capacity.
The activationmechanisms of the two other serineproteases, Der p 6
(chymotrypsin-like) and Der p 9 (collagenase), are still unknown. The
proDer p 6 propeptide (34 amino acids) is somewhat different from
chymotrypsinogen in that the arginine that normally occurs before the
trypsin cleavage site is replaced by a glycine [12].
Comparison of the propeptide C-terminal sequences from the mite
zymogens highlights the similarity of sequences that correspond to
the cleavage speciﬁcity by Der p 1 (Table 1) [13]. These observations
suggest the existence of a particular activation cascade for the mite
proteases. Unlike the major HDM allergens Der p 1 and Der p 2, Der p
6 is poorly characterised. This allergen was ﬁrst identiﬁed as a
chymotrypsin-like protease (provisionally named DP5) by Yasueda
et al. [14] and is expected to account for a large portion of the measur-
able proteolytic activity in HDM extracts [11]. While the contribution
of serine proteases to anti-mite IgE binding is considered low [15], the
global prevalence of anti-group 6 IgE varies between less than 10% to
65% [14,16–19], most probably because of the variability observed in
the preparation of natural allergens [20–22]. Therefore, obtaining
recombinant allergen Der p 6 for RAST determination and diagnosis
would be of interest to accurately evaluate the involvement of the
protease in mite allergy.
Our objectives were to elucidate the speciﬁc activation cascade
of the four mite zymogens based on the Förster Resonance Energy
Transfer (FRET) method. In parallel, we conﬁrmed the activation
mechanism of the proDer p 6 zymogen for which recombinant protein
is not yet available, by producing it in the yeast Pichia pastoris. The
roles of the propeptide in inhibiting the enzymatic activity of Der p 6
and in its activation were elucidated. Finally, we determined the





acetate, Boc-Gln-Ala-Arg-AMC acetate salts, Boc-Gln-Ala-Arg-p-
nitroanilide (pNA), N-succinyl-Ala-Ala-Pro-Phe-pNA and N-succinyl-
Ala-Ala-Pro-Leu-pNA were purchased from Bachem (Babendorf,
Switzerland). The cysteine protease inhibitor L-trans-epoxysuccinyl-
leucylamido (4-guanidino) butane (E-64) and soybean trypsin inhibitor
(SBTI) were obtained from Sigma (Saint Louis, USA). A polyclonal anti-
proDer p 6 antibody (rabbit) was manufactured by Eurogentec (Liège,
Belgium) using recombinant proDer p 6 and was puriﬁed with protein
A HiTrap (GE healthcare, Saint Louis, USA).
2.2. Mites and extracts
D. pteronyssinus was reared in the Earth and Life Institute (UCL,
Belgium). They were reared at 20 °C and 75% humidity as previously
described [23]. In some rearing boxes, mites were starved until death.
Afterwards, rearing boxes contained the bodies of the dead mites, the
exuviae (resulting from the successivemoults) and the faeces produced
by mites D. pteronyssinus culture extracts were obtained as previously
described [11].
2.3. Solid-phase synthesis of S1–S9 peptides
The S1, S3, S6 and S9 peptides correspond to the proDer p 1, proDer
p 3, proDer p 6 and proDer p 9 zymogen activation sites, respectively
(Fig. 1 in supplemental data). N-α-Fmoc amino acids were purchased
from Iris Biotech GmbH (Marktredwitz, Germany), and 2,4-
Dinitrophenyl (Dnp)-L-Proline and Dnp-L-Valine were obtained from
Sigma (Saint Louis, USA), and Dnp-L-Leucine came from TCI Europe
(Zwijndrecht, Belgium). The Glu and Thr side chains were protected
with a t-butyl derivative; Lys was protected with an N-epsilon-allyl-
oxycarbonyl group; and Asn was protected with a trityl group. The
substrates were prepared following a solid-phase peptide synthesis
strategy on a PS3 automated peptide synthesiser (Protein Technologies,
Inc., Tucson, AZ) using N-(7-Methoxycoumarin-4-yl)acetyl (AMC)-N′-
Fmoc-ethylenediamine-MBP-AM resin (Novabiochem, Darmstadt,
Germany), as previously described [11]. The side chain-protecting
groups were removed, and the peptides, which were cleaved from the
resin using triﬂuoroacetic acid (TFA)/anisole/water (6 ml; 10:1:1) during
a 3-hour incubation at room temperature, were precipitatedwith diethyl
ether.
2.4. Characterisation of S1–S9 peptides
The purity of each peptide (50 μl, 500 μM) was assessed via analyt-
ical HPLC performed on a Nucleodur C18 column (250 × 4.6 mm, 5 μm,
Macherey-Nagel, Düren, Germany). The HPLC chain consisted of a
pump (Waters 600) and a UV detector (PDA Waters 996, Hilford,
Massachusetts, USA). The absorbances at 323 nm and 374 nm, corre-
sponding to the AMC and Dnp groups, respectively, were constantly
recorded. The solvents consisted of aqueous and 0.1% acetonitrile (V/V)
TFA solutions. Elution was carried out for 30 min at a ﬂow rate of
1 ml/min using a linear gradient from 0 to 75% acetonitrile/TFA. Each
peptide (100 μl, 50 μM) was then characterised via electrospray
ionisation mass spectrometry (ESI-MS, TSQ 7000 Thermoquest
Finnigan, positive ionisation, 4.5 kV).
2.5. FRET measurements
Unglycosylated recombinantmatureDer p 1 (rDer p 1)was obtained
from proDer p 1 produced in P. pastoris as described previously [10,11].
The reaction mixtures contained 8 μM substrate (S1–S9) and rDer p 1
(0.04 μM for S3 and S6 and 2.32 μM for S1 and S9) or HDM extract
(1 mg/ml) in polybuffer (mixture of 50 mM Tris, phosphate, citrate,
acetate and KCl containing 1 mM DTT and 1 mM EDTA, adjusted to
pH 7.4), with or without the addition of the cysteine protease inhibitor
L-trans-epoxysuccinyl-leucylamido (4-guanidino)butane (E-64, 100 μM)
or the serine protease inhibitor soybean trypsin inhibitor (SBTI, 10 μM).
The time course of hydrolysis was monitored for 300 s in an LS 50 B
ﬂuorimeter (PerkinElmer Life Sciences) with excitation and emission
wavelengths of 328 and 393 nm, respectively.
Table 1
Activation sites of Dermatophagoides pteronyssinus zymogens. The underlined residues
correspond to the speciﬁcity of Der p 1 determined by [13]. The arrow indicates the
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2.6. Identiﬁcation of the S1–S9 peptide cleavage sites
The peptides (500 μM) were incubated with rDer p 1 (2.32 μM),
rDer p 3 (0.23 μM) or HDM extract (1 mg/ml) in 50 mM polybuffer at
pH 7.4, with or without the addition of either E-64 (100 μM) or SBTI
(10 μM), for 16 h at 25 °C. The fragments obtained after the various
treatments were separated via analytical HPLC as described above and
analysed via ESI-MS.
2.7. Kinetic parameters of rDer p 1 and HDM extracts
To control the proportionality of the FRET response to substrate
utilisation and to avoid the inner ﬁlter effect [24], calibration was per-
formed by completely hydrolysing the four substrates at concentrations
ranging from 0.5 to 40 μM using rDer p 1 (0.04 μM for S3 and S6 and
2.32 μM for S1 and S9). Hydrolysis was monitored via ﬂuorimetry as
described above for 180 min at 25 °C. FRET remained linear up to an
8 μM product concentration. For determination of the kinetic parame-
ters of rDer p 1 (0.04 or 2.32 μM) and the HDM extract (1 mg/ml), the
hydrolysis rates were measured for increasing substrate concentrations
(0 to 8 μM), and the data were analysed according to the Henri–
Michaelis–Menten equation.
2.8. Expression of recombinant proDer p 6 in P. pastoris
The proDer p 6 gene sequence, optimised for expression in
P. pastoris, was synthesised by GeneArt (Life Technologies, Paisley,
UK). The gene was inserted in a pPIC9K (Invitrogen, Paisley, UK) vector
that had been previously digested with the SnaBI and AvrII restriction
enzymes (Promega, Madison, USA).
The P. pastoris SMD1168 strain (Invitrogen, Paisley, UK) was trans-
formed through electroporation with the expression vector, which
had been linearised by the PmeI restriction enzyme. Transformants
from pPIC9K carrying the HIS4 gene were grown in histidine-deﬁcient
medium (RDB). Clones with multiple integrated copies were selected
using increasing geneticin concentrations (0.25 to 1 mg/ml, Invitrogen,
Paisley, UK).
For expression of proDer p 6, P. pastoris was grown in buffered
glycerol complete medium (BMGY) for 24 h at 28 °C to an A600 value
of ~25. The culture was then centrifuged for 15 min at 10000 g, and
the pellet was resuspended in buffered methanol complex medium
(BMMY) (0.5% methanol) for 2 days at 28 °C to measure protein
expression. The culture was subsequently centrifuged for 15 min at
10000 g, and the supernatant was conserved at−20 °C.
2.9. Puriﬁcation of recombinant proDer p 6 and of recombinant and native
Der p 6
The yeast culture supernatant was ﬁltered through a 0.45 μm ﬁlter
(Millipore, Darmstadt, Germany) and dialysed overnight at 4 °C against
20 mM Tris–HCl pH 7.5 (buffer A). The solution was then stirred with
200 ml of QXL streamline matrix (GE Healthcare, Saint Louis, USA)
that had been equilibratedwith buffer A at 4 °C. Thematrixwaswashed
with buffer A and packed into a column (GE Healthcare, Saint Louis,
USA). Bound proteins were eluted with buffer A containing 0.5 M
NaCl. After SDS-PAGE analysis, fractions containing proDer p 6 were
pooled and dialysed overnight at 4 °C against buffer A. The protein
was then precipitated by the addition of 60% ammonium sulphate at
4 °C. After centrifugation, the pellet was resuspended in 3 ml of buffer
A and dialysed overnight at 4 °C. The solution was then loaded onto a
Sephacryl S-100 HR column (120 ml) that had been previously equili-
brated with buffer A, and proteins were eluted according to molecular
weight. The fractions containing proDer p 6 were pooled and stored at
−20 °C.
The recombinant proDer p 1 protease (N-64A, N52A), fused with a
C-terminal six-histidine sequence, was produced in P. pastoris and
then puriﬁed and activated to a mature protease as described previously
[10]. This enzymewas incubatedwithMagneHis™Ni-Particles (Promega,
Madison, USA) overnight at 37 °C, and the particles with coated Der p 1
werewashedwith PBS containing 1 mMDTT and EDTA prior to incuba-
tion with proDer p 6 for 8 h at 37 °C. After the activation of proDer p 6,
the particles were removed, and pure rDer p 6 was stored at−20 °C.
To purify natural Der p 6, HMD extracts (4 g suspended in 40 ml of
PBS) were dialysed overnight at 4 °C against 20 mM Tris–HCl at
pH 7.5 (buffer A). The solution was then loaded onto a Q-HP HiTrap
column (GE Healthcare, Saint Louis, USA) equilibrated with buffer A.
Bound proteins were eluted with buffer A containing 1 M NaCl.
The fractions containing Der p 6 were pooled and loaded onto a
Benzamidine Sepharose 4 Fast Flow column (GE Healthcare, Saint
Louis, USA) that had been equilibrated with buffer A containing 0.5 M
NaCl. The proteins were eluted with 100 mM sodium acetate, pH 4,
and then dialysed overnight at 4 °C against buffer A. The solution was
next loaded onto a heparin column (GE Healthcare, Saint Louis, USA)
that had been equilibrated with buffer A. Elution was performed with
buffer A containing 1 M NaCl. The concentration of the obtained pro-
teins was estimated using the BCA assay (Thermo Scientiﬁc, Rockford,
USA). SDS-PAGE analysis and protease activities were assayed at each
stage of puriﬁcation as previously described [11].
2.10. N-terminal sequencing
The proDer p 6 and rDer p 6 proteins were sequenced in an Applied
Biosystems 476A protein sequencer based on Edman degradation. The
samples were analysed via SDS-PAGE, followed by electrophoretic
transfer to a polyvinylidene diﬂuoride membrane (Merck Millipore,
Darmstadt, Germany).
2.11. In vitro activation of recombinant proDer p 6
The proDer p 6 zymogen (3.5 μM)was incubated at 37 °C for 90 min
with either rDer p 1 (0.1 μM) or HDM extract (20 μg/ml) in 50 mM
polybuffer, pH 7.4, containing 1 mM DTT and 1 mM EDTA. The E64
inhibitor (100 μM), SBTI (10 μM) and/or the Der p 1 propeptide
(10 μM, produced and puriﬁed as previously described [10]) were also
added to the HDMextract prior to incubationwith proDer p 6. The sam-
ples were analysed via SDS-PAGE, and Der p 6 activity was measured in
20 mM Tris, pH 7, using the Ala-Ala-Pro-Phe-AMC substrate (200 μM).
The time course of hydrolysis was monitored for 300 s in an LS 50 B
ﬂuorimeter (PerkinElmer Life Sciences) with excitation and emission
wavelengths of 360 and 480 nm, respectively. The kinetics of hydrolysis
were reported as the time course of AMC (μM) release, using an AMC
(Sigma, Saint Louis, USA) standard curve with concentrations ranging
from 0 to 15 μM.
2.12. Der p 6 enzymatic activity measurements and determination of
kinetic parameters
For the determination of natural or recombinant Der p 6 (80 nM)
kinetic parameters, the rate of the hydrolysis of increasing AAPF-AMC
(Bachem, Babendorf, Switzerland) concentrations (0 to 400 μM) was
measured as described above, and the data were analysed according
to the Henri–Michaelis–Menten equation.
The optimum pH for rDer p 6 (0.1 μM) was also determined in
50 mM polybuffer at pH 4 to 11 with the same substrate (400 μM).
2.13. Determination of the role of the propeptide
2.13.1. Inhibition of recombinant Der p 6 by its propeptide
The peptide corresponding to the full-length propeptide of proDer p
6 (34 amino acids), was purchased from JPT Peptide Technologies
GmbH (Berlin, Germany). rDer p 6 activity (50 nM) was measured at
37 °C in 20 mM Tris pH 7 and using increasing concentrations of the
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peptide (0 to 60 μM) in the presence of the AAPF-AMC substrate at
different concentrations (25 to 100 μM). The inhibition model was
determined with a Hanes plot, and the inhibition constant, KI, was ob-
tained using the following equation:
vi ¼ V S= KM  1þ I=KIð Þ þ Sð Þ
where vi, V, S, I, KM and KI represent the initial rate of product release
(μM/s), the maximal rate of product release (μM/s), the concentration
of the substrate or inhibitor (μM), the KM of the enzyme for its substrate
(μM) and the inhibition constant (μM), respectively.
2.13.2. Mass spectrometry analysis of proDer p 6 propeptide degradation
The proDer p 6 prosequence (3 μM) was incubated with either rDer
p 6 or rDer p 1 (50 nM) in 20 mMTris, pH 7, and aliquotswere collected
at different times. The reactionwas stoppedwith 0.1% TFA, and the pep-
tides were desalted using Ziptips C18 (Millipore, Darmstadt, Germany).
The peptideswere then suspended in 50/50H2O/Acetonitrile (v/v), 0.1%
formic acid solution. ESI-MS analyses were performed on a Q-TOF
UltimaGlobalmass spectrometer (Micromass, nowWaters,Manchester,
UK). The ESI source was operated in positive ion mode at a capillary
voltage of 3 kV. The source block temperature was 100 °C, the
desolvation gas (N2) temperature was 200 °C and the source pressure
was 2.8 mbar. The RF Lens 1 voltage was set to 100 V. All mass spectra
were acquired over the 90–3000 m/z range and were processed with
MassLynx 4.1 software (Waters).
2.14. Immunolocalisation of Der p 1 and Der p 6
Mites were collected with a brush under a Nikon SMZ645 stereomi-
croscope (Nikon Belux, Brussels, Belgium) and then incubated over-
night in a solution of 2% formaldehyde and 0.05% Triton X-100 in PBS
at 4 °C. After three washes in PBS, the mites were incubated in a 30%
sucrose solution for 1 h at room temperature and then oriented in
7.5% agar, 15% sucrose. The mites were embedded in OCT compound
(VWR International, Poole, England), and incubated at −70 °C in an
isopentane bath. Cryosections (14–16 μm thick) were obtained by
means of a cryostat (Microm HM 560, Prosan) and collected on glass
slides. For immunolabeling, cryosections were dried at 30 °C before
being ﬁxed in 2% formaldehyde. After three washes in PBS, the sections
were soaked for 30 min at 37 °C in 10% normal goat serum (Sigma,
St Louis, USA) in PBS, and after immersed with 1:750 anti-Der p 6 and
1:1000 anti-Der p 1 (5H8, Indoor biotechnologies, USA) in PBS with
5% goat serum. They were washed in PBS, and immersed for 35 min at
37 °C in a PBS solution containing 1:250 goat anti-rabbit Alexa Fluor
594 and goat anti-mouse Alexa Fluor 488 (Molecular Probes, Leiden,
The Netherlands). The unbound antibodies were removed by three
washing cycles in PBS. The slides were immersed in a solution of DAPI
(1:50000 dilution; 4′,6-DiAmidino-2-PhenyIndole; Sigma Aldrich) and
washed with PBS. Finally, the sections were mounted with Citiﬂuor
AF1 (Laborimpex, Brussels, Belgium). Negative control sections were
realized by using normal goat serum instead of the primary antibodies.
The sections were observed under an Olympus IX71 confocal micro-
scope (Olympus America Inc.).
3. Results and discussion
The allergenicmite proteases Der p 1, Der p 3, Der p 6 andDer p 9 are
synthesised as inactive zymogens that thenmature into active enzymes
through speciﬁc cleavage of their propeptides. As recombinant allergens
are increasingly used for the diagnosis and treatment of allergy [21,25],
understanding the activation mechanisms of these zymogens repre-
sents an essential step for obtaining proteins with enzymatic and
folding properties similar to those of their natural counterparts. In the
future, elucidation of such activation cascades should provide insight
into the critical enzyme(s) involved in the onset of the activation
process and, thus, offer new opportunities for the development of ther-
apeutic drugs.
3.1. Kinetic parameters of S1–S9 peptides cleavage
To explore the proteolytic cascade occurring in mites, we synthe-
sised four peptides, termed S1, S3, S6 and S9 (Fig. S1, supplemental
data), which contained the activation sites of proDer p 1, proDer p 3,
proDer p 6 and proDer p 9, respectively.
The major allergen rDer p 1 was found to recognise and cleave all
of the synthesised substrates (Fig. 1). TheKMvalues for S3 and S6 hydro-
lysis by rDer p 1 were similar (b9 μM), but we unfortunately could not
measure the KM values for S1 and S9 because of the quenching of
ﬂuorescence at high peptide concentrations (N10 μM). The catalytic
efﬁciency (kcat/KM) of rDer p 1 for S1 (220 ± 20 mM−1 min−1)
was ~7- and 4-fold lower than that observed for S3 (1610 ±
20 mM−1 min−1) and S6 (860 ± 170 mM−1 min−1), respectively
(Table S1, supplemental data). This observation might be explained by
the fact that intermolecular activation of proDer p 3 (S3) and proDer p
6 (S6) by small amounts of Der p 1 was likely to require a higher
speciﬁcity than the auto-activation of proDer p 1 (S1). Finally, the
~7-fold lower kcat/KM value of rDer p 1 determined for S9 (31 ±
5 mM−1 min−1) might be due in part to the absence of a proline at
the P4 position and, especially, to the presence of a leucine instead of
an alanine at the P2 position.
This result is consistent with the demonstrated speciﬁcity of Der p 1
[13], which exhibits a preference for small hydrophobic residues in the
P2 position (Schechter and Berger's nomenclature [26]). We also
showed via mass spectrometry that all of the tested peptides were
hydrolysed in presence of HDM extracts (Table 2 and Fig. S2, supple-
mental data), and the obtained KM values were similar to those
observed using pure rDer p 1 (Table S1, supplemental data). The respec-
tive contributions of the cysteine and serine proteases present in HDM
extracts to the hydrolysis of S1, S3, S6 and S9 were then determined
by performing the reactions in the presence of cysteine (E-64) or serine
(SBTI) protease inhibitors. We found that the hydrolysis rates for the
four substrates were similar with or without the addition of SBTI
(Fig. 1, black and white bars), whereas they were strongly reduced in
the presence of E-64 (Fig. 1, grey bars). Nearly complete inhibition by
E-64 was observed when using puriﬁed rDer p 1.
These experiments demonstrate the high activity of Der p 1 in the
cleavage of S1, S3, S6 and S9 and suggest that Der p 1 plays a major
role in the activation of the four proDer p zymogens.
3.2. Identiﬁcation of cleavage sites
We showed that Der p 1 (either recombinant or in HDM extracts)
cleaved the presented peptides at the expected sites, i.e., between the
P1 and P′1 positions of the activation sites of the zymogens (Table 2
and Fig. S2, supplemental data). This can be explained by the presence
of similar residues at the C-terminal end of the zymogen prosequences,
which correspond to the speciﬁcity of Der p 1 [13]. These observations
validated our methodology by conﬁrming the role of Der p 1 as an
auto-catalytic enzymeand in proDer p 3maturation.More interestingly,
this study broadens the established activating role of themajor allergen
Der p 1 to include all mite protease zymogens. Indeed, the addition of
E-64 inhibited the speciﬁc cleavage of all of the peptides at the predicted
processing sites.
Nevertheless, a small amount of non-speciﬁc hydrolysis of S1 was
observed when using HDM extracts (Table 2). We showed that the
presence of additional peptide fragments was due to the activity of
serine proteases, as this phenomenon was totally abolished in the pres-
ence of SBTI. These data suggest that whereas Der p 1 is involved in the
activation of zymogens, the serine proteases are likely to be responsible
for non-speciﬁc protease degradations.
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3.3. Expression, puriﬁcation and activation of recombinant proDer p 6
We determined the activation mechanism for the recombinant
proDer p 6 zymogen. ProDer p 6 was expressed in the culture superna-
tant of P. pastoris after 36 h of methanol induction, and 1 mg of the
zymogen was then puriﬁed from 1 l of culture. SDS-PAGE analysis
(Fig. 2A, lane pDp6) indicated that proDer p 6 was present in two pre-
dominant forms with apparent molecular masses of 30 and ~28 kDa.
A sequence analysis indicated that these forms corresponded to the
entire zymogen (molecular mass of 28834 Da) and to proDer p 6 with
the25 N-terminal residues deleted (proDer p 6′: 25872 Da), respectively.
Recombinant proDer p 6 was then incubated in the presence of
either rDer p 1 or HDM extracts. SDS-PAGE analysis was performed
(Fig. 2A and B), and the time course of chymotrypsin activity was
analysed using AAPF-AMC (Fig. 2G). The two bands (~30 and 28 kDa)
corresponding to proDer p 6 and proDer p 6′ disappeared over time
after the addition of rDer p 1, and a new band corresponding to rDer p
6 appeared (~25 kDa) (Fig. 2B). The expected N-terminal sequence
(V35IGGDQ) of rDer p 6 was conﬁrmed. The incubation of proDer p 6
with rDer p 1 or HDM extracts for 1 h led to fully activated Der p 6.
The loss of the propeptide was related to an increase in chymotrypsin
activity. The maximum activity was reached after 60 min (Fig. 2G).
The same results were obtained following the addition of HDM
extracts previously incubated with SBTI (~20 kDa) to proDer p 6, sug-
gesting that serine proteases do not participate in the activation of the
zymogen (Fig. 2C). In contrast, the addition of the cysteine protease
Table 2
Identiﬁcation of cleavage sites of the S1–S9 peptides after hydrolysis by rDer p 1 or HDMextracts. Analytical HPLC analysis of peptides after their incubationwith rDer p 1 or HDMextracts
in presence or absence of inhibitors was performed followed by the characterization of the different peaks obtained by ESI-MS. The serine protease inhibitor is the Soybean-Trypsin
Inhibitor (SBTI) and the cysteine protease inhibitor is the E-64. M+ indicates the molecular mass of the peptide. ND is not determined.
Peptides rDer p 1 HDM extracts HDM extracts + E-64 HDM extracts + SBTI
Fragments M+ Fragments M+ Fragments M+ Fragments M+
S1 Dnp-LNAE 612 Dnp-LNAE 612 / Dnp-LNAE 612
TNA-MCA 563 TNA-MCA 563 / TNA-MCA 563
+ Non speciﬁc cleavages Non speciﬁc cleavages
Dnp-LNAETN 827 Dnp-LNAETN 827
AETNA-MCA 763 AETNA-MCA 763
ETNA-MCA 691 ETNA-MCA 691
NA-MCA 462
S3 Dnp-PNAT 569 Dnp-PNAT 569 / ND ND
IVGG-MCA 603 IVGG-MCA 603 Dnp-PNATIVGG-MCA 1152
S6 Dnp-PIAG 522 Dnp-PIAG 522 / ND ND
VIGG-MCA 603 VIGG-MCA 603 Dnp-PIAGVIGG-MCA 1108
S9 Dnp-PLG 451 Dnp-PLG 451 / ND ND
IVGG-MCA 603 IVGG-MCA 603 Dnp-PLGIVGG-MCA 1036
Fig. 1. Cleavage of S1, S3, S6 and S9 substrates. Enzymatic activity of rDer p 1 (0.04 μM or 2.32 μM) or HDM extracts (1 mg/ml) measured with 8 μM (A) S1, (B) S2, (C) S3 and (D) S9 in
absence (black) or presence of 100 μM E-64 (grey) or 10 μM SBTI (white).
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inhibitor (E-64) to rDer p 1 or HDM extracts totally abolished rDer p 6
production (data not shown and Fig. 2D, respectively) and no chymo-
trypsin activity was detected (Fig. 2G). Moreover, in the absence of
DTT, which enhances the activity of cysteine proteases, very weak acti-
vation of proDer p 6 by rDer p 1 or HDM extracts was observed (Fig. S3,
supplemental data).
To further conﬁrm the role of cysteine protease Der p 1 in the activa-
tion mechanism of proDer p 6, HDM extracts were pre-incubated with
the highly speciﬁc inhibitory propeptide of Der p 1 (KD 7 nM [10]).
The rate of activation of proDer p 6 in the presence of suchHDMextracts
was drastically delayed (Fig. 2E and G). It is noteworthy that the gain of
proDer p 6 activation after 30 min is due to the degradation of the
propeptide of Der p 1 by serine proteases of HDM extracts [27]. Indeed,
the addition of SBTI abolished this phenomenon and no activation could
be observed (Fig. 2F), whereas SBTI alone was not able to inhibit the
proDer p 6 activation by HDM extracts (Fig. 2C). Therefore, in the
absence of Der p 1 activity, no auto-activation of proDer p 6 could be
observed. The intermolecular activation of proDer p 6 conﬁrmed the
results of the FRET experiments and the crucial role of the cysteine pro-
tease Der p 1.
After activation of proDer p 6 with rDer p 1, rDer p 6 was puriﬁed.
The catalytic parameters of natural and recombinant Der p 6 were
measured using AAPF-AMC and were found to be similar. Indeed, the
KM values were (120 ± 10) μM and (40 ± 10) μM and the kcat values
were (0.38 ± 0.01) s−1 and (0.38 ± 0.01) s−1 for nDer p 6 and rDer
p 6, respectively. The optimum pH was determined to be 7, although
the protease displayed high activity (more than 90%) between pH 6
and 10 (Fig. S4, supplemental data).
3.4. Determination of the role of the propeptide
The mechanism underlying the maturation of the inactive zymogen
proDer p 6 mediated by Der p 1 corresponds to loss of the propeptide
and an increase in chymotrypsin activity, suggesting that the propeptide
covalently linked to the protease acts as an inhibitor of Der p 6. To
explore the role of this propeptide in the inhibition of Der p 6 when it
is free in solution, the prosequence was synthesised. We measured the
inhibition constant of the propeptide for rDer p 6 using AAPF-AMC as a
reporter substrate in either the absence or presence of increasing con-
centrations of the peptide. The Hanes plot (Fig. S5 supplemental data)
obtained using different concentrations of inhibitor shows that the
propeptide acts as a competitive inhibitor, with an inhibition constant
of (11 ± 2) μM.
Nevertheless, after a 1 minute incubation of the propeptide with
rDer p 6, an increase of chymotrypsin activity was observed, indicating
that the prosequence could be processed by the protease. To conﬁrm
this hypothesis, a mass spectrometry analysis of the propeptide in the
presence of rDer p 6 was performed. Fig. 3 shows the results of ESI-MS
analysis of the propeptide alone (Fig. 3A) and after a 5 minute incuba-
tion with rDer p 6 (Fig. 3C). This analysis was also performed in the
Fig. 2. Inter-molecular activation of proDer p 6 by rDer p 1 or HDM extracts in presence or absence of SBTI, E-64 and/or Der p 1 propeptide. SDS-PAGE analysis: proDer p 6 (pDp6) was
incubated at 37 °C in polybuffer with 1 mM DTT/EDTA pH 7.4 with (A) HDMe; (B) rDer p 1; (C) HDMe with SBTI, (D) with E64, (E) with propeptide of Der p 1 or (F) with propeptide
and SBTI.(E) rDer p 6 activity for each activation time (0 to 90 min) in presence of rDer p 1 (blue diamond shapes), HDMextracts (black circles), HDMewith propeptide (dark grey circles)
and HDM extracts with E-64 (light grey circles).
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presence of rDer p 1 (Fig. 3B). The peptide was found to be cleaved in
several places by the two proteases (Fig. 3D). However, the sites of
hydrolysis are different for the two proteases and correspond to their
respective cleavage speciﬁcities. Indeed, rDer p 6 and rDer p 1 cleaved
the peptide after aromatic (tryptophan and leucine) or positively
charged (arginine, lysine and serine) residues, respectively.
Here, we demonstrated that the propeptide inhibits the proteolytic
activity of Der p 6. However, whereas this inhibition is very stable
when the propeptide is covalently linked to the protease, the free
propeptide in solution is quickly cleaved by Der p 6 as well as Der p 1,
rendering it unable to inhibit the neo-formed Der p 6.
3.5. Immunolocalisation of Der p 1 and Der p 6 in D. pteronyssinus
We determined the localisation of Der p 6 and Der p 1 in
D. pteronyssinus. Examination of coronal sections under a confocal
microscope revealed that Der p 6 immunoreactivity is only present in
the digestive tract and, more speciﬁcally, in the hindgut (Hg) following
the terminology of Brody et al. [28]. Indeed, Der p 6 was observed in
cells in the absence of ingested material and in the gut lumen (red
ﬂuorescence, Fig. 4A andB). Similar localisation patternshave previously
been observed for Der f 3, the Der p 3 homologous found in D. farinae
[9].
Protease Der p 1 was localised in lining cells of the anterior midgut
(AMg, yellow ﬂuorescence, Fig. 4C) and in the lumen of the posterior
midgut (PMg, Fig. 4D), as previously reported by Thomas et al. [7].
Fig. 4C and D shows that Der p 1 and Der p 6 are co-localised in the
hindgut (Hg, orange ﬂuorescence).
Previous observations of the digestive tract of the mite showed that
cells lining the anterior midgut, where pH is comprised between 4 and
5, would be gradually detached in the gut lumen and would then be
taken in the faecal pellets in the posterior midgut and the hindgut,
where pH reaches 6 [28–30]. It is thus likely that the auto-activation
of proDer p 1 occurring at acidic pH proceeds in the anterior midgut,
thereby providing active protease Der p 1. As the Der p 1 displays a
high activity at pH 6 [10], it may activate the proDer p 3 and proDer p
6 zymogens, and most probably proDer p 9, in the hindgut where the
serine proteases and Der p 1 were co-localised (Fig. 5) [7,9].
Fig. 3.Mass spectrometry analysis. ESI-QTOF analysis of (A) the peptide corresponding to
the propeptide of proDer p 6 (3 μM) and the peptide after 5 minute incubation with
50 nM (B) rDer p 1 or (C) rDer p 6; (D) represents the propeptide sequence and the
arrow indicates the cleavage sites of rDer p 1 (red) and rDer p 6 (blue).
Fig. 4. Immunolocalisation of Der p 1 and Der p 6 in longitudinal sections of Dermatophagoides pteronyssinus body. (A–B) Localisation of Der p 6 (red ﬂuorescence) in the posterior midgut
and (C–D) co-localisation of Der p 1 (green ﬂuorescence) in the anterior to posterior gut with Der p 6 only detected in posterior part. Mite bodies are in blue ﬂuorescence with DAPI. The
scale bar is 50 μM. AMg, anterior midgut; Hg, hindgut; PMg, posterior midgut.
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4. Conclusion
Our ﬁndings demonstrate that Der p 1 is essential for the activation
of the mite protease zymogens proDer p 1, proDer p 3, proDer p 6 and
probably proDer p 9 (Fig. 5). Moreover, a similar proteolytic cascade
might also occur inD. farinae and Euroglyphusmaynei, as thepropeptides
of the corresponding zymogens in these species exhibit a high degree of
similarity with those of D. pteronyssinus (Table S2, supplemental data).
According to the critical role of proteolytically active HDM protease
allergens in the initiation and in the chronicity of the allergic response,
the elucidation of the proDer p 6 maturation process will provide a
source of recombinant highly pure and fully active Der p 6 allergen
offering new opportunities to deeply characterise its proteolytic speci-
ﬁcity and to better deﬁne its roles in the activation of innate immune
pathways.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2013.11.017.
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Fig. 5. Proteases activation cascade in the digestive tract of the mite Dermatophagoides
pteronyssinus. The box represents the activation cascade in the hindgut. AMg, anterior
midgut; FP, faecal pellet; Hg, hindgut; PMg, posterior midgut.
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